Micro Imaging Technology Acquires Cellmyx, Expanding Aesthetic and Regenerative Medicine Portfolio

Micro Imaging Technology, Inc. (MMTC) announced the acquisition of Cellmyx, a company specializing in medical technologies for orthopedic physicians, pain management, and regenerative medicine. This acquisition is expected to strengthen MIT's ability to expand and manufacture its existing products nationally and worldwide, adding to its portfolio in the aesthetic, cosmetic surgery, and regenerative medicine space. Cellmyx is known for its FDA-cleared intelliFat® BOD™ technology.